AU7568794A - Hiv (vif)-related compositions, and prophylactic and therapeutic uses thereof - Google Patents
Hiv (vif)-related compositions, and prophylactic and therapeutic uses thereofInfo
- Publication number
- AU7568794A AU7568794A AU75687/94A AU7568794A AU7568794A AU 7568794 A AU7568794 A AU 7568794A AU 75687/94 A AU75687/94 A AU 75687/94A AU 7568794 A AU7568794 A AU 7568794A AU 7568794 A AU7568794 A AU 7568794A
- Authority
- AU
- Australia
- Prior art keywords
- vif
- hiv
- prophylactic
- therapeutic uses
- related compositions
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
- C12N15/1131—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against viruses
- C12N15/1132—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against viruses against retroviridae, e.g. HIV
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16311—Human Immunodeficiency Virus, HIV concerning HIV regulatory proteins
- C12N2740/16322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Virology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- AIDS & HIV (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11022693A | 1993-08-20 | 1993-08-20 | |
US110226 | 1993-08-20 | ||
PCT/US1994/009313 WO1995005851A1 (en) | 1993-08-20 | 1994-08-19 | HIV vif-RELATED COMPOSITIONS, AND PROPHYLACTIC AND THERAPEUTIC USES THEREOF |
Publications (1)
Publication Number | Publication Date |
---|---|
AU7568794A true AU7568794A (en) | 1995-03-21 |
Family
ID=22331893
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU75687/94A Abandoned AU7568794A (en) | 1993-08-20 | 1994-08-19 | Hiv (vif)-related compositions, and prophylactic and therapeutic uses thereof |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU7568794A (en) |
WO (1) | WO1995005851A1 (en) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6776986B1 (en) | 1996-06-06 | 2004-08-17 | Novartis Ag | Inhibition of HIV-1 replication by antisense RNA expression |
JP4418101B2 (en) * | 1997-09-18 | 2010-02-17 | ザ・トラスティーズ・オブ・ザ・ユニバーシティ・オブ・ペンシルバニア | Attenuated vifDNA immunization cassette for genetic vaccines |
CN1339320A (en) * | 2000-08-18 | 2002-03-13 | 清华大学 | AIDS vacuum and its preparing method and use |
ATE343591T1 (en) | 2001-04-06 | 2006-11-15 | Univ Jefferson | ANTAGONIST FOR MULTIMERIZATION OF HIV-1 VIF PROTEIN |
EP1629003B1 (en) | 2003-05-23 | 2008-03-12 | Oregon Health & Science University | Methods for identifying inhibitors |
US20050222068A1 (en) | 2003-10-23 | 2005-10-06 | Mourich Dan V | Method and antisense composition for selective inhibition of HIV infection in hematopoietic cells |
US8158770B2 (en) | 2004-05-06 | 2012-04-17 | University Of Rochester | Content dependent inhibitors of cytidine deaminases and uses thereof |
EP2376633A1 (en) | 2008-12-17 | 2011-10-19 | AVI BioPharma, Inc. | Antisense compositions and methods for modulating contact hypersensitivity or contact dermatitis |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2752788B2 (en) * | 1989-01-23 | 1998-05-18 | カイロン コーポレイション | Recombinant therapy for infection and hyperproliferative disorders |
DE69033311T2 (en) * | 1989-06-02 | 2000-02-17 | Institut National De La Sante Et De La Recherche Medicale I.N.S.E.R.M., Paris | Nucleotide sequences of the genome of retroviruses of the HIV-1, HIV-2 and SIV types, their uses for the amplification of these genomes and the in vitro diagnosis of these viral infections |
FR2647809B1 (en) * | 1989-06-02 | 1991-09-20 | Pasteur Institut | OLIGONUCLEOTIDE PRIMERS FOR THE AMPLIFICATION OF THE GENOME OF HIV-1, HIV-2 AND SIV RETROVIRUSES AND THEIR APPLICATIONS TO IN VITRO DIAGNOSIS OF INFECTIONS DUE TO THESE VIRUSES |
GB8923123D0 (en) * | 1989-10-13 | 1989-11-29 | Connaught Lab | A vaccine for human immunodeficiency virus |
-
1994
- 1994-08-19 AU AU75687/94A patent/AU7568794A/en not_active Abandoned
- 1994-08-19 WO PCT/US1994/009313 patent/WO1995005851A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO1995005851A1 (en) | 1995-03-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU7564694A (en) | Erection-inducing methods and compositions | |
AU7323294A (en) | Perfluoroelastomeric compositions and methods | |
AU8123294A (en) | Electrical initiator | |
AU7207094A (en) | Wrist brace | |
AU7138394A (en) | N,n-diacylpiperazines | |
AU5494294A (en) | Hop extract and use thereof | |
AU8074694A (en) | Keyboard | |
AU1248395A (en) | Bandages | |
AU5794094A (en) | Tricritical point composition | |
AU9075591A (en) | N-halochitosans, their preparation and uses | |
AU4167493A (en) | Polyfluorohydrocarbon group-containing acrylates, their polymers and applications of the polymers | |
AU5505794A (en) | Alkali-treated bagasse, and its preparation and uses | |
AU7796494A (en) | Compositions including two hydrofluorocarbons | |
AU7957794A (en) | Anti-allergic, anti-inflammatory compounds, compositions and uses | |
AU7320894A (en) | Red powder articles, compositions and methods | |
NZ250863A (en) | Pseudopeptides, preparation and antiviral compositions | |
AU5798996A (en) | Adnaz, compositions and processes | |
AU7568794A (en) | Hiv (vif)-related compositions, and prophylactic and therapeutic uses thereof | |
AU5922694A (en) | 2-amino-4-quinolyl-dihydropyridines, processes for their preparation, and their use | |
AU1441195A (en) | Phenylmethyl hexanamides, and the use thereof | |
AU7741394A (en) | High tear strength silicone compositions | |
AU5773994A (en) | Cable-making compositions | |
AU6511294A (en) | Tonometer | |
AU3286993A (en) | Explosive composition, manufacture and use thereof | |
AU6242494A (en) | Slip resistant compositions and uses |